A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...
Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...